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Vein interposition cuffs decrease the
intimal hyperplastic response of
polytetrafluoroethylene bypass grafts
Mark Kissin, MD, Nikhil Kansal, MD, Peter J. Pappas, MD, David O.
DeFouw, PhD, Walter N. Durán, PhD, and Robert W. Hobson II, MD,
Newark and East Orange, NJ
Purpose: The modification of the distal anastomosis of polytetrafluoroethylene (PTFE)
bypass grafts with vein interposition cuffs (VCs) has been reported to increase graft
patency. However, the mechanisms that are responsible for this improved patency are
unclear. Because intimal hyperplasia (IH) is a primary cause of prosthetic graft failure,
we hypothesized that VCs affect the distal anastomosis by decreasing the IH response of
the outflow artery.
Methods: Twenty-three female domestic Yorkshire pigs (mean weight, 35 kg) underwent
42 femoral PTFE bypass grafting procedures. The PTFE bypass grafts were separated
into the following three groups according to distal anastomotic configuration: end-to-
side anastomoses (ES), VCs, and cuffs constructed with PTFE (PCs). Four femoral
arteries from two pigs served as healthy controls. At sacrifice, the grafts were perfusion
fixed, and the distal anastomoses harvested at 1 and 4 weeks. The specimens were hemi-
sected and serially sectioned to identify the heel, toe, and mid-anastomotic regions. The
sections were cut into 5-µm segments and analyzed for intima and media thickness and
area, intima/media area ratio, and the distribution of IH in the vein cuff. The roles of
transforming growth factor–β1 and platelet-derived growth factor–BB in IH develop-
ment were assessed with immunohistochemistry.
Results: IH development was significantly lower at all areas of the anastomosis, with VCs
compared with ES and PCs at 4 weeks (P ≤ .001). IH decreased in VCs from 1 to 4
weeks in all areas of the anastomosis (P ≤ .001). PCs showed pronounced IH at the mid-
anastomosis as compared with VCs and ES (P ≤ .001). IH was most pronounced at the
toe with ES and PCs (P ≤ .001). Qualitatively, VCs altered the site of IH development,
sparing the recipient artery with preferential thickening of the vein cuff and formation
of a pseudointima at the vein-PTFE interface. Immunohistochemistry results showed
positive staining for transforming growth factor–β1, platelet-derived growth factor–BB,
and smooth muscle α-actin in the hyperplastic intima.
Conclusion: PTFE bypass grafts with VCs had less IH develop than did grafts with ES
and PC anastomoses. IH regression in VCs at 4 weeks suggests compensatory vessel wall
remodeling mediated by the presence of the VC. Furthermore, VCs caused a redistribu-
tion of hyperplasia to the vein-PTFE interface, delaying IH-induced outflow obstruc-
tion in the recipient artery. The marked increase in IH with PCs, despite a similar geo-
metric configuration to VCs, suggests that the biologic properties of autogenous tissue
dissipate IH development. Similarly, the flow patterns in PCs and VCs should be iden-
tical, which suggests a less important role of hemodynamic forces in VC-mediated pro-
tection. (J Vasc Surg 2000;31:69-83.)
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The autologous saphenous vein remains the con-
duit of choice for patients who require infrainguinal
revascularization.1,2 The lack of a suitable or available
autologous saphenous vein as the result of phlebitis,
varicosities, previous limb revascularization, coronary
artery bypass grafting, or poor caliber emphasizes the
need for alternative bypass graft conduits.3 Accessory
saphenous veins, arm veins, lesser saphenous veins,
composites (spliced vein vs a prosthetic plus a vein),
and synthetic grafts alone have all shown acceptable
short-term patency rates and limb salvage rates.4-9
Similar results have been reported with adjunctive
modifications at the distal anastomosis of prosthetic
grafts and the concomitant use of warfarin therapy.9-13
However, poor long-term patency rates with alterna-
tive conduits and prosthetic graft adjuncts and the
lack of randomized, prospective, multicenter trials
with these techniques have tempered their wide-
spread use.13
Prosthetic expanded polytetrafluoroethylene
(ePTFE) grafts are commonly used alternative con-
duits because of their biocompatability, good han-
dling properties, ability to be manufactured in large
quantities, lack of aneurysmal dilatation, and absence
of intrinsic intraluminal defects.1 In an effort to
improve long-term graft patency, vein patches or
interpositon vein cuffs have been added as adjunctive
modifications to the distal anastomoses of prosthetic
bypass grafts.10-12,14-16 A recent review of our insti-
tution’s clinical experience with vein interposition
cuffs (VCs) and of one single-center randomized
clinical trial has documented improved patency rates
as compared with the rates of non-cuffed ePTFE
bypass grafts.16-19
Although the clinical data suggest improved
efficacy with VCs, few investigations have identi-
fied the mechanisms responsible for this improved
response.20,21 Because prosthetic grafts accelerate
the development of intimal hyperplasia (IH) at the
heel, the toe, and the base of the recipient outflow
artery, we hypothesized that VCs improve patency
by modifying the degree and distribution of distal
anastomotic IH.22-24 Therefore, the purpose of
this investigation was to quantitatively and qualita-
tively assess the IH response of recipient outflow
arteries in a porcine model after prosthetic bypass
grafting anastomoses, with and without adjunctive
modifications.
METHODS
Study design and rationale. Forty-two 6-mm
ePTFE bypass grafts (Exxcel, Boston Scientific/
Vascular, Oakland, NJ) were placed in 23 female
domestic Yorkshire pigs (30 to 36 kg). A porcine
model was chosen for the following reasons: (1)
numerous investigators have demonstrated repro-
ducible IH lesions after balloon angioplasty of the
porcine coronary, femoral, and carotid arteries; (2)
porcine arteries are histologically and biochemically
similar to those of humans; (3) an intima consisting
of elastic tissue, collagen, and scattered smooth mus-
cle cells and endothelia is present; (4) porcine arter-
ies are large enough to receive prosthetic bypass graft
conduits; and (5) pigs have a coagulation system that
is similar to that of humans, and therefore they avoid
the hypercoaguable states that are observed with
canine models.25,26
The pigs were separated into the following three
groups according to distal anastomotic configura-
tion, which consisted of the following at 1 and 4
weeks, respectively: (1) traditional end-to-side anas-
tomoses (ES; n = 5; n = 6); (2) VCs fashioned in the
manner described by Raptis and Miller16 (n = 5; n =
9); and (3) PTFE interposition cuffs (PCs), which
were constructed in the laboratory and autoclaved
before insertion (n = 6; n = 6). The controls con-
sisted of healthy femoral arteries harvested from pigs
that had not undergone bypass grafting (n = 4). The
PC group was included to address issues of anasto-
motic angle and compliance and control for flow
pattern influences. The VC and PC groups had iden-
tical configurations, with essentially 90° interfaces
between the prosthetic graft and the recipient artery.
With the graft configuration and angle kept con-
stant, the flow pattern forces were eliminated as
independent variables in the development of distal
anastomotic IH between these two groups. The bio-
logic properties of the interposition cuff material
become the determinate variable and an indirect
assessment of compliance. The ES group similarly
addresses compliance issues and angulation. All the
ES anastomoses were less than 90° and greater than
30°. The differences in IH between the ES and PC
groups should therefore represent the effect of anas-
tomotic angulation because both grafts were in
direct contact with the target outflow artery, which
resulted in compliance mismatch.
Surgical procedures. After intramuscular seda-
tion with ketamine hydrochloride (33 mg/kg), ace-
promazine maleate (0.1 mg/kg), and atropine (0.02
mg/kg), a 20-gauge intravenous needle was placed
in an ear vein, and animal hair at the surgical site was
shaved. Tetracycline (22 mg/kg) was administered
intravenously during surgery and after surgery for
two doses, and maintenance intravenous fluids were
administered. After intubation, the animals were
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anesthetized with isoflurane and oxygen at a maxi-
mum alveolar concentration between 1 and 3. Pulse
oximetry, bovie cautery, grounding pads, tempera-
ture mats, sheepskin, and rectal temperature probes
were placed before the prepping and draping.
The external jugular vein or the hind limb greater
saphenous vein was used to construct the VC. Once
harvested, the vein was transected longitudinally and
inspected for the presence of valves or phlebitis. The
acceptable segments were sutured onto the distal anas-
tomosis of a 6-mm ePTFE graft (Exxcel). The grafts
with PTFE cuffs were constructed in the laboratory
and autoclaved before surgery. The venous donor sites
were closed with a running 2-0 polyglactin 910 sub-
cutaneously and a running 2-0 silk for the skin closure.
Incisions were subsequently made in each hind limb
groin, and the common femoral, profunda femoris,
and superficial femoral (SFA) arteries were identified
and dissected out. The branches of the SFA were indi-
vidually ligated with 4-0 silk. Porcine heparin (100
mg/kg) was administered intravenously, and 6-mm
grafts were sutured into 4-mm arteries in the usual
manner with 6-0 Prolene (Ethicon, Somerville, NJ).
The proximal anastomosis was sutured at the common
femoral artery–SFA junction. The distal anastomosis
was sutured to the distal SFA. The length of the graft
was between 7 and 8 cm. At the completion of the
anastomoses, a 2-0 tie was placed in the mid-portion
of the bypassed femoral artery to ensure preferential
flow through the bypass graft. The immediate graft
patency was confirmed with continuous wave Doppler
scan results. Identical graft configurations within each
animal were avoided. The wounds were subsequently
closed as described previously. The incisions were cov-
ered with an occlusive dressing and maintained for 24
hours.
Postoperative pain was managed with intravenous
buprenorphine hydrochloride (0.3 mg/mL/ampule)
every hour as needed. Graft patency was determined
with manual palpation, weekly duplex ultrasound
scanning, and a duplex scan on the day of harvest.
For surveillance ultrasound scanning, the pigs were
sedated as stated previously and mask ventilated.
On the day of harvest, the pigs were sedated and
an ear vein was cannulated. After the dissection of the
proximal portions of the graft, the animals were killed
with an intravenous injection of 60 mL of saturated
potassium chloride (Fischer Scientific, Springfield, Ill).
Clamps were placed on the proximal portions of the
graft, and the distal portions were perfusion fixed with
a 10% formalin solution (Sigma, St Louis, Mo) at a
pressure of 100 mm Hg for 15 to 20 minutes. After
perfusion fixation, the distal anastomosis and adjacent
veins were harvested en bloc and placed in a 10% for-
malin solution. All the animal studies were approved
by the University of Medicine and Dentistry of New
Jersey–New Jersey Medical School’s Institutional
Animal Care Committee and performed within the
guidelines of the National Institutes of Health.
Specimen processing. The specimen blocks
were removed from the formalin fixatives within 24
hours, after which they were trimmed, hemisected,
and transferred to a 70% alcohol solution. The spec-
imens were subsequently moved to a tissue proces-
sor (rotary open Auto-Technicon tissue processor
model 2A, The Technicon Company, Tarrytown,
NY) for overnight processing in 70%, 80%, 95%, and
100% graded ethyl alcohol solutions, two exchanges
with a xylene (Sigma, St Louis, Mo) clearing agent,
and molten paraffin. After the tissues were oriented,
the specimens were embedded in paraffin blocks,
allowed to solidify, chilled, and cut into 5-µm 
sections on a rotary microtome (Olympus 4060)
(Olympus America Inc, Melville, NY). After section-
ing, the specimens were mounted on Superfrost Plus
slides (EMS, Fort Washington, Pa) for morphomet-
ric analyses and immunohistochemistry.
Morphometric analysis. Serial 5-µm sections
from paraffin-embedded blocks were analyzed until
areas corresponding to the middle, heel, and toe of
the anastomoses were identified (Fig 1). The repre-
sentative sections were deparaffinized in xylene and
rehydrated with 100%, 95%, 90%, 70%, and 50%
graded ethyl alcohol solutions, followed by distilled
water. After hydration, the slides were stained with
Verhoeff ’s elastic stain and van Gieson’s counter-
stain. Measurements were obtained with videomi-
croscopy (Nikon Optiphot-2 microscope, Garden
City, NY) and image analysis software (Image-Pro
Plus, Media Cybernetics, Silver Spring, Md). The
morphometric variables that were assessed were inti-
ma and media thickness, intima and media area, and
intima/media area ratios (intima area/intima area +
media area). The intimal and medial boundaries
were determined by means of digital planimetry.
Four sections from each heel, toe, and mid-anasto-
mosis per specimen were inspected. For each sec-
tion, 16 intima and media thickness measurements
and four non-overlapping intima and media area
measurements were performed for a total of 64 inti-
ma and media thickness and 16 intima and media
areas per specimen. The area measurements were
standardized with a fixed micrometer for a length of
100 µm.
Immunohistochemistry. Immunohistochemistry
analyses were performed with affinity purified poly-
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clonal antibodies to human transforming growth fac-
tor–β1 (TGF-β1), platelet-derived growth factor–BB
(PDGF-BB), and smooth muscle α-actin. The follow-
ing were the primary antibodies: (1) polyclonal, affin-
ity purified, chicken anti-human TGF-β1 immuno-
globulin G (IgG) antibody (1:20 dilution; R&D
Systems, Minneapolis, Minn); (2) polyclonal, affinity
purified, goat anti-human PDGF-BB IgG antibody
(1:20 dilution; R&D Systems); and (3) monoclonal,
mouse anti–α actin IgG2a (smooth muscle) antibody
(1:500 dilution; Boehringer-Manheim, Indianapolis,
Ind). The biotinylated secondary antibody for TGF-β1
was a goat anti-chicken IgG antibody (1:750 dilution;
Vector Laboratories, Burlingame, Calif). Biotinylated
secondary antibodies and blocking agents for PDGF-
BB and smooth muscle α-actin staining were supplied
as part of The Vectastain Elite ABC detection kits
(Vector Laboratories) and the Histostain-Plus Broad
Spectrum kit (Zymed, San Fancisco, Calif), respective-
ly. The blocking reagent used for TGF-β1 was a goat
IgG antibody from goat serum (Vector Laboratories).
For each antibody, the dilution that yielded the opti-
mal specific staining was determined in pilot experi-
ments.
As stated, the blocks were sectioned, mounted
onto poly-L-lysine–coated slides, heated to 60°C,
dehydrated with serial xylene, and rehydrated in serial
ethyl alcohol dilutions. To facilitate antigen exposure,
the sections were rinsed in 1× phosphate-buffered
saline solution (PBS; Sigma), heated in a 1× saline
sodium citrate solution (Sigma) in a microwave for 20
seconds, and left in the hot solution for 30 minutes.
Once deparaffinized, the sections were digested with
0.2% hyaluronidase solution for 30 minutes at 37°C,
followed by incubation in a 3% hydrogen peroxide
solution for 10 minutes to exhaust endogenous perox-
idase activity. The blocking reagents were applied for
20 minutes at room temperature and rinsed with PBS.
The primary antibodies were applied for 3 hours at
room temperature, followed by a washing with PBS.
Biotinylated secondary antibodies for TGF-β1 (2
µg/mL or 1:750 dilution) were applied for 30 min-
utes at room temperature. For PDGF-BB and smooth
muscle α-actin staining, the supplied secondary anti-
bodies were used as directed for 30 minutes and 10
minutes, respectively, at room temperature. After
being rinsed with PBS, the slides were developed with
a streptavidin-horseradish peroxidase complex for 30
minutes at room temperature, followed by diamino-
benzidine substrate (Vectastain Elite ABC Kit). The
positive reactions appeared to be dark brown with
light microscopy. The smooth muscle α-actin–stained
specimens were counterstained with hematoxylin and
eosin for 1 minute. All the sections then were rehy-
drated with serially increasing ethyl alcohol dilutions
before the placement of a cover slip. The sections of
pig spleen underwent the same preparation and analy-
sis and served as positive controls. The negative con-
trols consisted of the previously mentioned investiga-
tions without the primary antibody.
Statistical analysis. The differences between the
mean ± the standard error of the mean between
groups were analyzed with a one-way analysis of vari-
ance and the Newman-Keuls post hoc tests. The dif-
ferences between timepoints within groups were ana-
lyzed with a two-tailed Student t test. Significance
was accepted at a P value of less than .05. The data
were analyzed with the statistical software package
GraphPad Instat (GraphPad Software, San Diego,
Calif).
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Fig 1. Areas of anastomosis corresponding to heel, base, and toe, where serial 5-µm sections
for morphometric measurements and qualitative histologic and immunohistochemistry analy-
ses were performed.
RESULTS
Graft patency. Forty-two grafts were placed in
23 domestic Yorkshire pigs. Five graft occlusions
were noted and discarded from the analysis. One ES,
one VC, and three PC grafts occluded during the
study period.
Histology and morphometric analysis. IH
was identified by the thickness of the intima layer,
defined as the tissue that extends between the lumen
and the internal elastic lamina. Both the internal and
the external elastic laminas were well stained and
demarcated as dark wavy lines with the van Gieson’s
counterstain method. The intima and media layers
were evaluated for thickness and area at several
points in the heel, base, and toe sections of the
recipient artery at the predetermined timepoints.
The results of the morphometric evaluations are pre-
sented in Tables I to VI, which are arranged by anas-
tomotic configuration and period of observation.
Fig 2 is a montage of the IH responses observed
with each graft configuration after transverse sec-
tioning of the middle of the anastomosis. A progres-
sion in the IH response was observed in the VC, ES,
and PC groups as compared with the controls at 4
weeks. A modest increment in intima thickness was
detected in the artery that received a vein cuff, with
the worst response noted in the artery that received
a PTFE-cuffed anastomosis.
Fig 3 graphically illustrates the distribution and
relative magnitude of the IH responses associated
with each anastomosis that was evaluated, with par-
ticular emphasis on the effect at the heel, base, and
toe of the distal anastomosis.
We qualitatively analyzed serial vein cuff sections
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Fig 2. Verhoeff’s elastic stain and van Gieson’s counterstain results of mid-anastomotic sec-
tions at 4 weeks from each study group showing progressively increasing intimal thickening
with vein cuff, end-to-side, and polytetrafluoroethylene (PTFE) grafts compared with control
(magnification, 440×).
Table I. Morphologic data at the anastomotic heel at 1 week
Control (n = 4) VC (n = 6) ES (n = 5) PC (n = 5) P value
Intima thickness (µm) 13 ± 0.6 42 ± 1.44 40 ± 1.54 84 ± 6.3 *,†,‡
Media thickness (µm) 268 ± 8 514 ± 5.1 355 ± 4.4 381 ± 6.2 *,†,‡
Intima area (µm2) 1248 ± 123 4188 ± 237 4104 ± 274 8659 ± 1280 *,§
Media area (µm2) 26838 ± 1660 52284 ± 1041 35679 ± 938 38638 ± 1326 §(P ≤ .05),†
VC, Vein cuff; ES, end-to-side; PC, polytetrafluoroethylene.
Data are expressed as mean ± standard error of the mean. All values are significant at P ≤ .001, unless otherwise stated.
*Control group versus all groups.
†PC group versus VC and ES groups.
‡VC group versus ES group.
§Control group versus ES and PC groups only.
to assess the morphologic alterations that occur with-
in vein cuffs and between the artery vein and vein-
PTFE interface. Fig 4 shows the progression of IH in
the artery as it approaches the vein cuff artery anasto-
mosis. The intima of the outflow artery increases as it
approaches the vein cuff. The internal elastic lamina
and external elastic lamina of the artery and vein cuff
are clearly identified. Intimal thickening of the vein
cuff is clearly shown, indicating a shift of the IH
response away from the target artery and to the cuff-
graft interface.
To standardize the comparisons, we calculated the
intima/media area ratios at the heel, base, and toe of
the anastomosis for each study group. The statistical
analysis results are presented in Figs 5 to 7. Fig 5
depicts the results for intima/media area ratios
obtained at the heel of the anastomoses. Only modest
changes in intima/media area ratios were measured
after 1 week. PC and ES grafts showed intima/media
area ratios that were significantly greater as compared
with those of the controls (P ≤ .05), and VC grafts did
not differ from control arteries. The intima/media
area ratio increased in the ES and PC groups at 4
weeks, relative to their ratio at 1 week after the graft-
ing procedure (P ≤ .001). At 4 weeks, large increases
were identified in ES and PC grafts as compared with
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Table II. Morphologic data at the anastomotic heel at 4 weeks
Control (n = 4) VC (n = 6) ES (n = 6) PC (n = 9) P value
Intima thickness (µm) 12.8 ± 0.6 12.6 ± 0.334 234 ± 18 390 ± 13 *,†,‡
Media thickness (µm) 268 ± 8 351 ± 5.8 364 ± 9 804 ± 13 *,†,‡
Intima area (µm2) 1248 ± 123 1306 ± 61 23524 ± 3570 38324 ± 2492 §,†,
Media area (µm2) 26838 ± 1660 34404 ± 1155 35607 ± 1803 80051 ± 2680 ¶,†
VC, Vein cuff; ES, end-to-side; PC, polytetrafluoroethylene.
Data are expressed as mean ± standard error of the mean. All values are significant at P ≤ .001, unless otherwise stated.
*Control group versus all groups.
†PC group versus VC and ES groups.
‡VC group versus ES group.
§Control group versus ES and PC groups only.
ES group versus VC group.
¶Control group versus PC group only.
Fig 3. Magnitude of intimal hyperplasia (IH) responses at heel, toe, and mid-anastomosis
within each study group at 4 weeks. End-to-side grafts showed pronounced IH at the toe com-
pared with polytetrafluoroethylene (PTFE) and vein cuff grafts. PTFE grafts primarily affect-
ed the base and heel of anastomosis, whereas vein cuff grafts showed minimal IH at any site.
VC grafts and controls (P ≤ .001). Of note, a regres-
sion in the intima/media area ratio occurred in the
VC group, such that the intima/media ratio for the
VC group at 4 weeks was significantly less than the
corresponding ratio at 1 week after the grafting pro-
cedure. Similar regressions were noted at the base and
toe of the anastomosis.
The base or the mid-anastomotic region, with
one notable exception, did not exhibit significant
changes in intima/media area ratio at either 1 week
or at 4 weeks after anastomosis (Fig 6). The only
remarkable change at these time periods was a sig-
nificant increase in intima/media area ratios in the
PC grafts. These ratios were significantly elevated as
compared with the VC, ES, and control ratios (P ≤
.001). Also, the change in intima/media area ratio
in PC grafts at 4 weeks was significantly greater than
the change in PC intima/media area ratio at 1 week
(P ≤ .001). In general, the intima/media area ratio
changes that were observed in PC grafts at the mid-
anastomotic region were slightly smaller than those
observed at the heel of the anastomosis.
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Fig 4. Verhoeff’s elastic stain and van Gieson’s counterstain results of vein cuff anastomosis
showing shift of intimal hyperplasia response from artery-vein cuff interface to vein cuff–pros-
thesis interface. Arrows indicate internal elastic lamina of artery and vein cuff. Triangles indicate
external elastic lamina of recipient artery. Thick arrows indicate external elastic lamina of vein
cuff. Long downward arrow points to location of suture hole of underlying vein graft (magnifi-
cation, 74×). PTFE, Polytetrafluoroethylene.
Table III. Morphologic data at mid-anastomosis at 1 week
Control (n = 4) VC (n = 6) ES (n = 5) PC (n = 5) P value
Intima thickness (µm) 13 ± 0.6 28.8 ± 1.5 29.3 ± 0.75 55 ± 1.9 *,†,‡
Media thickness (µm) 268 ± 8 302 ± 6.5 283 ± 4.2 373 ± 4.6 *,†,‡
Intima area (µm2) 1248 ± 123 2743 ± 307 2555 ± 133 5160 ± 392 *(P ≤ .05),†
Media area (µm2) 26838 ± 1660 30549 ± 1311 29340 ± 888 37232 ± 914 §,†
VC, Vein cuff; ES, end-to-side; PC, polytetrafluoroethylene.
Data are expressed as mean ± standard error of the mean. All values are significant at P ≤ .001, unless otherwise stated. 
*Control group versus all groups.
†PC group versus VC and ES groups.
‡VC group versus ES group.
§Control group versus PC group only.
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Fig 5. Bar graph of intima/media (I/M) area ratios from heel of each study group at 1 and 4
weeks. Within each group, there were significant differences between 1 and 4 weeks (P ≤ .001).
ES, End-to-side; PC, polytetrafluoroethylene cuff; VC, vein cuff.
*VC4 versus ES4 and PC4 (P ≤ .001).
#VC4 versus VC1 (P ≤ .001).
+VC1 versus PC1 (P ≤ .001).
Fig 6. Bar graph of intima/media (I/M) area ratios from mid-anastomosis of each study
group at 1 and 4 weeks. Within each group, there were significant differences between 1 and
4 weeks (P ≤ .001). Vein cuff (VC) and end-to-side (ES) grafts did not differ at 1 and 4 weeks.
PC, Polytetrafluoroethylene cuff.
+PC1 and PC4 were significantly elevated compared with VC and ES grafts (P ≤ .001). 
Table IV. Morphologic data at mid-anastomosis at 4 weeks
Control (n = 4) VC (n = 6) ES (n = 6) PC (n = 9) P value
Intima thickness (µm) 13 ± 0.6 10 ± 0.3 29 ± 1.7 257 ± 13 *,†,‡
Media thickness (µm) 268 ± 8 234 ± 4.9 350 ± 8.82 493 ± 11 *,†,‡
Intima area (µm2) 1248 ± 123 905 ± 64 2516 ± 323 24093 ± 2426 §
Media area (µm2) 26838 ± 1660 23582 ± 989 34095 ± 1704 48557 ± 2044 §,‡
VC, Vein cuff; ES, end-to-side; PC, polytetrafluoroethylene.
Data are expressed as mean ± standard error of the mean. All values are significant at P ≤ .001, unless otherwise stated. 
*Control group versus all groups.
†PC group versus VC and ES groups.
‡VC group versus ES group.
§PC group versus all groups.
Fig 7 displays the analysis of the intima/media area
ratios in the toe region of the anastomosis. Significant
increases in intima/media area ratio occurred within a
given group between weeks 1 and 4 (P ≤ .05), except
for the PC group. At 1 week, a significant increase in
the intima/media area ratio for the PC grafts was
identified (P ≤ .001), and no significant differences
were present in VC and ES grafts relative to control
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Fig 7. Bar graph of intima/media (I/M) area ratios from toe of each study group at 1 and 4
weeks. Within each group, there were significant differences between 1 and 4 weeks (P ≤ .001).
ES, End-to-side; PC, polytetrafluoroethylene cuff; VC, vein cuff.
*VC4 versus ES4 and PC4 (P ≤ .001).
+PC1 was increased compared with ES1 and VC1 (P ≤ .001).
No differences were noted between PC4 and ES4.
Table V. Morphologic data at the anastomotic toe at 1 week
Control (n = 4) VC (n = 6) ES (n = 5) PC (n = 5) P value
Intima thickness (µm) 13 ± 0.6 25 ± 1.3 32 ± 2 64 ± 2.8 *,†,‡
Media thickness (µm) 268 ± 8 289 ± 5.7 239 ± 5.1 306 ± 5.2 *,†,‡
Intima area (µm2) 1248 ± 123 2484 ± 244 3022 ± 414 6340 ± 552 §,†
Media area (µm2) 26838 ± 1660 28272 ± 1124 23985 ± 1018 30310 ± 1042 
VC, Vein cuff; ES, end-to-side; PC, polytetrafluoroethylene.
Data are expressed as mean ± standard error of the mean. All values are significant at P ≤ .001, unless otherwise stated. 
*Control group versus all groups.
†PC group versus VC and ES groups.
‡VC group versus ES group.
§Control group versus PC group only.
ES group versus VC and PC groups.
Table VI. Morphologic data at the anastomotic toe at 4 weeks
Control (n = 4) VC (n = 5) ES (n = 6) PC (n = 9) P value
Intima thickness (µm) 13 ± 0.6 9 ± 0.22 116 ± 14.4 58 ± 3.7 *,†,‡
Media thickness (µm) 268 ± 8 321 ± 4.9 325 ± 7.26 317 ± 5.8 *,†,‡
Intima area (µm2) 1248 ± 123 1078 ± 48 11711 ± 2974 5860 ± 728 §(P ≤ .05),
(P ≤ .01)
Media area (µm2) 26838 ± 1660 32003 ± 976 32652 ± 1487 31218 ± 1145 NS
VC, Vein cuff; ES, end-to-side; PC, polytetrafluoroethylene.
Data are expressed as mean ± standard error of the mean. All values are significant at P ≤ .001, unless otherwise stated. 
*Control group versus all groups.
†PC group versus VC and ES groups.
‡VC group versus ES group.
§Control group versus PC group only.
ES group versus VC and PC groups.
and to each other. By 4 weeks, the increment in inti-
ma/media area ratio of the ES group became similar
to that achieved by the PC group. Both the ES and
PC groups displayed an intima/media area ratio
greater than the VC group at 4 weeks (P ≤ .001).
Immunocytochemistry. IH is one example of tis-
sue remodeling in response to stimuli. TGF-β1 and
PDGF-BB have been identified as major factors in
hyperplasia and tissue remodeling. To test whether or
not these factors play a role in prosthetic graft–induced
IH, we assessed their presence with immunohisto-
chemistry.
Fig 8 displays the presence of TGF-β1 immunore-
active products in the four study groups. Mild TGF-β1
staining is shown in the intima of the control artery.
The PC group shows positive staining of elliptical cells
in the intima. Diffuse non-specific intimal staining is
observed in the other study groups.
Fig 9 shows the distribution of PDGF-BB in the
intima of the study groups. PDGF-BB staining was
identified in elliptical cells of the intima in all the study
groups. To determine the nature of these elliptical
cells, we probed the tissue with antibodies to smooth
muscle α-actin. Fig 10 shows positive α-actin reaction
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Fig 8. Immunohistochemistry results for transforming growth factor–β1 showing staining of
elliptical cells in intima of polytetrafluoroethylene (PTFE) cuff group (inverted arrows).
Diffuse staining is observed in intima of other study groups. Thick arrows indicate location of
internal elastic lamina (magnification, 400×). gr, Graft.
Fig 9. Immunohistochemistry results for platelet-derived growth factor–BB showing positive
staining of elliptical cells in intima (inverted arrows). Thick arrows indicate location of internal
elastic lamina (magnification, 400×).
product results in the intimal elliptical cells. The pres-
ence of α-actin reaction products is consistent with
the these elliptical cells being smooth muscle cells
immersed in the intima of arteries undergoing IH.
DISCUSSION
Several investigators have proposed various
hypotheses to explain the possible mechanisms associ-
ated with increased prosthetic graft patency and
adjunctive vein cuffs at the distal anastomosis. The
prominent theories are that vein cuffs influence IH
development by promoting high shear stress flow pat-
terns via the cuff’s unique geometric configuration,
reduction of compliance mismatches at the distal
anastomosis, and inherent biologic properties of
autogenous tissue.14,27-29 The goal of the current
investigation was to directly and indirectly determine
the degree to which each of these variables is affected
by the presence of a vein cuff. Flow patterns for VC
and PC grafts were kept similar with the construction
of distal anastomoses with identical angles and geo-
metric configurations. The differences in distal anas-
tomotic IH development between these two groups
should therefore reflect the biologic properties of the
material used to construct the cuff. Similarly, ES and
PC grafts were in direct contact with the target out-
flow artery and differed only in anastomotic graft
angle and geometric configuration. The differences in
IH between these two groups should reflect the influ-
ence of graft angulation, and VC grafts should control
for geometic and biologic effects.
Our study results show a marked reduction in
the development of IH at the distal anastomosis of
prosthetic bypass grafts that use VCs as compared
with grafts with PTFE cuff interposition and stan-
dard ES anastomosis. Because VC and PC grafts
exhibited comparable anastomotic geometric con-
figurations and angulation, the superiority of VC
must be caused by the biologic properties of auto-
genous tissue. Our results are consistent with the
concept that the vein wall absorbs the multifactorial
impact of a prosthetic graft and effectively transfers
responses of reactive IH from the host artery to the
arterializing vein.
One possible explanation for this observation is a
reduction in compliance mismatch. Tyrrell et al14
have demonstrated decreased compliance mismatch-
es of vein cuffs and Taylor patches in an in vitro graft
model. These authors state that “…for any cylinder
under a given distending presssure, the stress applied
to the circumference is double that applied to the
length.” With the longitudinal cutting of a piece of
saphenous vein and the reorientation of the vein’s
axis, the cuff becomes anisotropic (more compliant)
longitudinally rather than transversely.14 However,
the direct influence of mechanical properties of veins
has been challenged by experiments that compared
vein cuffs with vein cuffs whose mobility was limited
by PTFE wrapping.20 Norberto et al20 reported no
differences in IH development between these two
groups and concluded that the mechanical proper-
ties of vein cuffs are not the primary variable modu-
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Fig 10. Immunohistochemistry results for smooth muscle α-actin showing staining of elliptical
cells within intima and media (arrowhead). Morphologically similar cells in intima similarly showed
positive stain results for transforming growth factor–β1 and platelet-derived growth factor–BB in
adjacent serial sections. Long arrow points to internal elastic lamina (magnification, 1400×).
lating IH development. The data from the current
study do not support this position. The only differ-
ence between PC and VC grafts was in the material
used to construct the cuff. This observation strong-
ly suggests that compliance differences between the
stiffer PTFE cuff and vein cuff may influence IH
development at the distal anastomosis.
Shear stress alterations that result from anasto-
motic configurations and material properties influ-
ence the development of IH.30-33 The graft angle at
the distal anastomosis is one of the determinants of
shear stress and flow pattern. The degree of angula-
tion contributes to turbulent flow vortices and areas
of low shear stress within the anastomosis.28,32-34
Because of these important considerations, we con-
structed the VC and PC with the same configura-
tion, so that the influence of geometry and flow pat-
terns would be accounted for in the experimental
design. The pronounced IH response of PCs as
compared with VCs strongly implies that stable flow
vortices are not as important as the presence of auto-
genous tissue.28 Thus, our data show that the bio-
logic properties of the material used to create the
cuff are responsible for the improved outcome in
our study.
The proliferation and migration of smooth muscle
cells from the media to the intima and the accumula-
tion of extracellular matrix in response to injury are
the hallmarks of IH.30 To assess the biologic proper-
ties that regulate these events in the presence of VCs,
we investigated the distribution and sites of various
cytokines known to modulate anastomotic IH devel-
opment. TGF-β1 and PDGF-BB are recognized as
two cytokines that play a major role in tissue remod-
eling and IH. Our results confirmed the presence and
apparent upregulation of TGF-β1 and PDGF-BB in
the intima and media of the host artery and in the
vein cuff. These cytokines are in the same location as
cells that stain positively to smooth muscle α-actin,
which suggests that the suppression of smooth mus-
cle cell cytokine production may limit the progression
of IH in the VC. The VC may therefore be a poten-
tial site for gene therapy–directed IH inhibition.
A prominent observation from this investigation
is a regression of IH in the VC group at 4 weeks as
compared with the PC and ES groups. We postulate
that the biologic properties of the vein cuff (eg, abil-
ity to respond functionally by cytokine synthesis,
release) are responsible for the improved results.
Because the vein cuff is the first biologic material to
interact as an interphase with the graft, it spares the
host artery the burden of strong stimuli for hyper-
plasia. The vein cuff dissipates the continuous injury
response that stimulates IH development in the
recipient artery and transfers the site of ongoing
injury to the graft-cuff interface. We believe that it is
this continuous injury response at the graft-cuff
interface that ultimately causes these grafts to fail.
The pronounced intimal reaction in the vein cuff, as
shown in Fig 4, supports this hypothesis.
In conclusion, prosthetic bypass grafts modified
with VCs decrease the IH response at target outflow
arteries as compared with traditional ES anasto-
moses and grafts modified with PCs. Grafts with PCs
showed exaggerated IH responses. Because PCs and
vein cuffs had identical configurations and similar
anastomotic angles, we presume that flow patterns
in the cuff were similar. The induction of IH with
cuffed configurations is therefore primarily depen-
dent on the material used and less affected by angu-
lation and configuration. The redistribution of
hyperplasia into the vein cuff and away from the cuff
artery interface suggests that intrinsic biologic prop-
erties of the vein cuff are primarily responsible for its
protective effect. Techniques that diminish the
development of IH in vein cuffs may therefore offer
potential therapies for extending prosthetic graft
patency further. Furthermore, our data suggest that
cuffed prosthetic grafts may promote IH develop-
ment and lead to early graft failure.
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Dr Anton N. Sidaway (Washington, DC). I congrat-
ulate Dr Kissin and his coauthors on a well-planned and
executed study aiming to shed more light on the protec-
tive mechanism of vein interposition cuff placed at the
outflow anastomosis of prosthetic bypass grafts. We have
become accustomed to the excellent work that your group
consistently produces, and this paper is no different.
I submit the following three comments and questions
to the authors.
First, the authors have shown, as we did, that the per-
pendicular angle of the vein cuff is not the factor that plays
the protective role. Probably the presence of venous auto-
genous tissue interposed between the prosthetic graft and
the artery provides an autogenous buffer zone, moving the
location of intimal hyperplasia to the graft-vein cuff anas-
tomoses. Because the diameter of this anastomosis is sig-
nificantly larger than a graft-artery anastomosis, the intimal
hyperplastic lesion plays less a role in the patency of the cuff
anastomosis. Did you analyze your data to show that sig-
nificant intimal hyperplastic lesions develop at the graft-
vein cuff anastomosis? In a way, did you compare the
thickness of the lesion encountered in this location with
that lesion that takes place at the arterial outflow?
Second, although the authors commented on the better
DISCUSSION
compliance match when vein interposition cuff is added to
the outflow anastomosis, they provided no data that mea-
sured compliance. In our previous study, we found that vein
cuff distensibility (and we tried to avoid using the term com-
pliance) plays no role in alleviating intimal hyperplasia in a
comparable model of graft placement in the canine carotid
artery. Do the authors have any data that implicate better
compliance match for the protective effect of the vein cuff?
Lastly, growth factors are known to be produced dur-
ing the process of intimal hyperplasia. The intimal hyper-
plasia produced with this model is no different. In addi-
tion, the fact that growth factors are produced in a lesion
does not show cause and effect. The interaction between
the growth factor and its receptor results in its mitogenic
effect. Did you perform any receptor binding studies to
detect receptor up regulation if any?
I would like to thank the Society for the privilege of
discussing this important paper. Thank you.
Dr Peter J. Pappas. Thank you, Dr Sidawy, for those
insightful comments.
Your first question was in regards to measurements in
the vein cuff itself. That was an insightful observation on
your part, because within our own group we discussed
whether or not this was intimal hyperplasia versus medial
hyperplasia or just overall hypertrophy. We are now going
back, and we are relooking at some of those vein wall speci-
mens to see whether we can more clearly identify the inter-
nal elastic lamina, because it is our suspicion that what we are
really looking at is arterial wall remodeling of the vein cuff
and not actually a hyperplastic response in the intima.
Your second question regarding compliance is also
insightful. We too had difficulties in trying to construct
methods to measure compliance. So, the best thing that we
could think of was to have a polytetrafluoroethylene cuffed
and a vein cuffed group, and we keept the configuration
identical so that the flow patterns would be similar and so
that the only difference would be that one anastomosis
would be made of autogenous tissue and that the other
would be made with prosthetic tissue. Although I will tell
you that at 1 and 4 weeks, when we harvested these speci-
mens, there was an intense reaction around the grafts. The
fibrosis was so great that I doubt the vein cuffs were expand-
ing with each pulsation, suggesting that any differences in
compliance eventually dissipate with time.
Your third question was the role of receptors and
growth factors in the observed hyperplastic responses. The
reason we looked at transforming growth factor–β1 and
platelet-derived growth factor–BB is because we hoped
that if the vein cuff did show efficacy that in the next series
of experiments we might be able to use gene therapy
approaches to try to modify the response in the vein cuff.
The fact that we did observe these growth factors and the
fact that it was reported in another series that these
growth factors are involved in the hyperplastic response
led us to confirm that perhaps there is an association. But
I agree with you that the next series of experiments needs
to look at the receptor function and also a cause and effect
relationship.
Dr Michael S. Conte (Boston, Mass). I want to con-
gratulate the authors both for an excellent presentation and,
even more so, for taking a difficult clinical and extremely
complex biologic problem to the animal laboratory.
I have just two questions. One is whether you looked,
in addition to thickness, on what happens to lumen? That
is, as time goes on, do you develop luminal narrowing in
this model? Is it actually a model of prosthetic graft steno-
sis? It would be very interesting if that were true.
Second, can you hypothesize a little bit more on the
mechanism? It appears that you have shown that the
geometry is not the issue. Is there perhaps a direct toxic
effect of the adjoining prosthetic graft, or what do you
speculate is happening at the interface between the pros-
thetic graft and the autogenous tissue? Thank you.
Dr Pappas. Again, those were insightful questions. We
tried to look at luminal narrowing when we were original-
ly designing the study. The problem is that it is much eas-
ier to look at luminal narrowing when you are dealing
with an angioplasty model in which the entire artery is cir-
cumferential. When you are analyzing an anastomosis and
you are dealing with a hemisection of the wall of the
artery, luminal narrowing becomes difficult to assess. So,
even though we thought about it, we could not think of
an accurate way in which to assess that, other than looking
at the outflow artery to see whether there were any vein
wall remodeling changes.
In regards to the mechanism, one of the things that
we were curious about was that when you look at these
prosthetic grafts in patients and when you perform your
duplex scans on them, you see what is referred to in the
literature as this stable vortex, which to me is just another
name for turbulence. I have always assumed that turbu-
lence will increase hyperplasia because of low shear stress
zones. And I did not understand how the cuff, with this
turbulent pattern, would decrease hyperplasia. I still do
not think that it is flow related, and I still do not think that
it is geometry related. My suspicion is that it has some-
thing to do with an inherent biologic property of the vein
cuff itself. And one of the suspicions I have is that when
you look at some of these sections, you see that the
endothelial cells and the smooth muscle cells reorient
themselves. So, there are obviously some biologic proper-
ties going on, and I am trying to dissect them out right
now. But I think it has something to do with cytokine
alterations and growth factors in the vein wall that affect
remodeling of the cuff and outflow artery.
Dr Joseph L. Mills (Tucson, Ariz). I enjoyed that pre-
sentation very much. As you know, we have been interest-
ed in this same topic. We have studied the Taylor vein
patch in a canine model and showed that intimal hyper-
plasia was reduced significantly with the vein patch. And
so your paper supports our bias that it is not just geome-
try, it is a biologic effect.
What I would like to ask you is, because you used
immunocytochemistry to look at smooth muscle cells with
alpha smooth muscle cell actin, have you looked at prolif-
eration rates in those smooth muscle cells? For example,
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you could do proliferating cell nuclear antigen. And is
smooth muscle cell proliferation reduced with the use of
the vein cuff?
Thank you.
Dr Pappas. Originally when we designed the study, we
were interested in that exact question, and we did give the
animals 5′-bromo-3′-deoxyuridine before they were killed.
However, we were unable to really get the 5′-bromo-3′-
deoxyuridine staining to work. Proliferating cell nuclear
antigen is another method in which you can use immuno-
cytochemistry to look at the nuclei within the cells. And no,
we have not done that as yet. But we have specimens that
we have sectioned and not stained yet. We certainly could
go back and reanalyze those specimens for proliferating cell
nuclear antigen using the imaging analysis software.
Dr Edmund J. Harris, Jr (Stanford, Calif). This was a
very nice study, but I ask whether you have duplicated one
modification of this experiment, originally reported by
Sidaway and his colleagues (Norberto JJ, Sidaway AN,
Trad KS, Sidawy MK, DePalma RG. The protective effect
of vein cuffed anastomoses is not mechanical in origin. J
Vasc Surg 1995;21:558-66). This group wrapped a vein
cuff with polytetrafluoroethylene to get at the question of
compliance mismatch. Have you wrapped these vein cuffs
with polytetrafluoroethylene in your model?
Dr Pappas. Although that is a good suggestion, I was
more concerned about trying to bring things back to the
clinical arena. And I am sure that you could wrap a piece of
polytetrafluoroethylene around a vein cuff after you have
done it in patients as well, but then that begs the question
of why not just construct a prosthetic graft that has a hood
anastomosis to it? I realize what you are saying about the
added beneficial effects of the vein cuff, but no, we had not
considered that as another limb.
Very briefly, to follow up on Dr Harris’ question, we
did use the wrap you suggested and we reported our
results in the Journal of Vascular Surgery (Norberto JJ,
Sidaway AN, Trad KS, Sidawy MK, DePalma RG. The
protective effect of vein cuffed anastomoses is not
mechanical in origin. J Vasc Surg 1995;21:558-66). In
the canine carotid artery model, we wrapped the vein cuff
on one side with a polytetrafluoroethylene jacket and we
kept the contralateral side vein cuff unwrapped. There
was no significant difference in the thickness of intimal
hyperplasia between the two sides. So, we believed that it
is not really distensibility or “compliance” that is protec-
tive, but that the presence of an autogenous tissue zone
between the graft and the artery moved the location of
the intimal hyperplasia from the graft-artery interface to
the graft-venous cuff interface.
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